NWL vs PCRX · rev $3.54B vs P/E 174, rev $369.8M
Newell Brands Inc (NWL) versus Pacira BioSciences, Inc. (PCRX) — a side-by-side from cached financials, not a winner call.
Newell Brands Inc (NWL) is a household & personal products company listed on NASDAQ.
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported NWL revenue for 2026-06-30 was $3.54B. Net income was $73.0M. NWL currently screens at market cap $2.11B.
Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
NWL currently screens at market cap $2.11B. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
Not investment advice. Open the NWL and PCRX stock pages for the full models.
Not investment advice.